Biotechnology company developing breakthrough oncology drugs directed to cancer stem cells (CSCs), the most dangerous & deadliest class of cancer cells
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free